Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO‐10‐27

Cynthia Bézier, Steve Cottin, Parvin Nazari Hashemi, Mirella El Khoury, Zoé Clerc, Christine Balducci, Delphine Sapaly, Laure Weill, René Lafont, Stanislas Veillet, Pierre J. Dilda, Frédéric Charbonnier, Mathilde Latil, Olivier Biondi

Open source

DOI
10.1002/jcsm.70104
Published
2025-10
Container
Journal of Cachexia, Sarcopenia and Muscle
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcsm.70104,
  title = {Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO‐10‐27},
  author = {Cynthia Bézier and Steve Cottin and Parvin Nazari Hashemi and Mirella El Khoury and Zoé Clerc and Christine Balducci and Delphine Sapaly and Laure Weill and René Lafont and Stanislas Veillet and Pierre J. Dilda and Frédéric Charbonnier and Mathilde Latil and Olivier Biondi},
  year = {2025},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  doi = {10.1002/jcsm.70104},
  url = {https://doi.org/10.1002/jcsm.70104}
}

RIS

TY  - JOUR
TI  - Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO‐10‐27
AU  - Cynthia Bézier
AU  - Steve Cottin
AU  - Parvin Nazari Hashemi
AU  - Mirella El Khoury
AU  - Zoé Clerc
AU  - Christine Balducci
AU  - Delphine Sapaly
AU  - Laure Weill
AU  - René Lafont
AU  - Stanislas Veillet
AU  - Pierre J. Dilda
AU  - Frédéric Charbonnier
AU  - Mathilde Latil
AU  - Olivier Biondi
PY  - 2025
JO  - Journal of Cachexia, Sarcopenia and Muscle
DO  - 10.1002/jcsm.70104
UR  - https://doi.org/10.1002/jcsm.70104
ER  - 

APA

Bézier, C., Cottin, S., Hashemi, P. N., Khoury, M. E., Clerc, Z., Balducci, C., Sapaly, D., Weill, L., Lafont, R., Veillet, S., Dilda, P. J., Charbonnier, F., Latil, M., & Biondi, O. (2025). Drug Candidate BIO101 for Spinal Muscular Atrophy as Monotherapy or Combined With the Antisense Oligonucleotide ASO‐10‐27. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70104

Source records